Delivery Order SPE2DB24D2018-SPE2DB25FWWL6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,926.33 to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Generation 5) 5S, medical devices used in diabetes management. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed pricing and was awarded on a competitive basis without a set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $7,826.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive procurement of specialized diabetic medical devices. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the delivery order through its corporate office division....
- The Defense Logistics Agency (DLA) awarded a $2,486.25 delivery order contract to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a Delivery Order valued at $3,775.06 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5), 5-pack units. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its corporate office location. This delivery order represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,921.93 firm fixed-price delivery order for OmniPod 5 Dexcom G7 Generation 5 pods on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWL6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,639.79 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) 5S, medical devices supporting diabetes management. This firm fixed price delivery order, executed on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Department of Defense and military healthcare systems. The company's comprehensive contract portfolio with the DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices spanning multiple therapeutic domains. This delivery order for diabetes management devices continues the company's substantial role in supporting military and veteran healthcare supply chains through competitive federal contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 8/27/25 |